Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of 0.28% sodium hyaluronate eye drops in dry eye disease
TCTR20210219002Phase 4Completed
- Sponsor
- National Innovation Agency
- Start
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of sodium hyaluronate in dry eye syndrome (DED), sponsored by National Innovation Agency. Started Sep 2020; status: completed.
02
Drugs
sodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on TCTR20210219002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210219002.